BRIEF published on 04/02/2026 at 04:05, 18 days 6 hours ago Aperçu des résultats financiers de MedMira Inc. pour le deuxième trimestre de l'exercice 2026 Perte Nette Résultats Financiers De MedMira Frais D'exploitation Partenariat McKesson Chiffre D'affaires Du Deuxième Trimestre De L'exercice 2026
BRIEF published on 04/02/2026 at 04:05, 18 days 6 hours ago MedMira Inc. Q2 FY2026 Financial Results Overview Net Loss Operating Expenses MedMira Financial Results McKesson Partnership Q2 FY2026 Revenue
PRESS RELEASE published on 04/02/2026 at 04:00, 18 days 6 hours ago MedMira Reports Second Quarter Results FY2025 MedMira Inc. reports partnership with McKesson, financial results and progress on new tests. The company aims to expand market reach and improve sales Financial Results Clinical Trials MedMira Inc. RVF Technology McKesson Partnership
BRIEF published on 12/31/2025 at 02:05, 3 months 20 days ago MedMira Reports First Quarter Results for FY2026 Health Canada MedMira Q1 Financials MiROQ Technology Reveal® TP
BRIEF published on 12/31/2025 at 02:05, 3 months 20 days ago MedMira publie ses résultats du premier trimestre de l'exercice 2026 MedMira Santé Canada Technologie MiROQ Reveal® TP Résultats Financiers Du T1
PRESS RELEASE published on 12/31/2025 at 02:00, 3 months 20 days ago MedMira Reports First Quarter Results FY2026 MedMira Inc. reports Health Canada approval for Reveal® TP (Syphilis) rapid test, progress in clinical trials, and financial results for Q1 FY2026 Financial Results Clinical Trials MedMira Inc. Health Canada Approval Reveal® TP
BRIEF published on 11/29/2025 at 03:05, 4 months 21 days ago MedMira Releases FY2025 Financial Performance Financial Results MedMira Diagnostic Tests FY2025 MiROQ Technology
BRIEF published on 11/29/2025 at 03:05, 4 months 21 days ago MedMira publie ses résultats financiers pour l'exercice 2025 Résultats Financiers MedMira Exercice 2025 Tests Diagnostiques Technologie MiROQ
PRESS RELEASE published on 11/29/2025 at 03:00, 4 months 21 days ago MedMira Reports FY2025 Fourth Quarter and Year End Financial Results MedMira Inc. reports on financial results for FY2025, including product launches, clinical trials, and commercial advancements. Details on revenue, profit, loss, and balance sheet highlights are provided Financial Results Clinical Trials MedMira Inc. Product Launches Commercial Advancements
BRIEF published on 08/26/2025 at 22:48, 7 months 24 days ago Santé Canada approuve le test rapide de dépistage de la syphilis de MedMira Syphilis MedMira Santé Canada Tests Rapides Maladie Infectieuse
Published on 04/20/2026 at 09:00, 1 hour 30 minutes ago Ameriwest Completes 3D Geological Model Defining High-Grade Copper Shell Along with Two Additional Zones at the Bornite Project
Published on 04/20/2026 at 08:00, 2 hours 30 minutes ago QNX and NVIDIA Deepen Collaboration to Advance Safety-Critical Edge AI Across Robotics, Medical, and Industrial Systems
Published on 04/20/2026 at 04:00, 6 hours 30 minutes ago Leapmotor Selects QNX for D19 Premium Electric SUV, Production Starts April 2026
Published on 04/20/2026 at 02:25, 8 hours 5 minutes ago First Challenger Assays Return Grades up to 170g/t Au
Published on 04/18/2026 at 04:00, 2 days 6 hours ago Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Published on 04/20/2026 at 10:05, 25 minutes ago CoCo Announces Strategic Partnership in Belgium to Accelerate European Expansion
Published on 04/20/2026 at 10:00, 30 minutes ago Humanoid robotics: Schaeffler wins Hermes Award for innovative actuator platform
Published on 04/20/2026 at 09:30, 1 hour ago KKCG Maritime Submits Board of Directors Candidate Slate for Ferretti Group Ahead of Annual General Meeting
Published on 04/20/2026 at 09:20, 1 hour 10 minutes ago CAMSO Construction Enters Key European Markets with Strong On-Ground Readiness
Published on 04/20/2026 at 09:17, 1 hour 13 minutes ago Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program
Published on 04/20/2026 at 08:00, 2 hours 30 minutes ago First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries
Published on 04/20/2026 at 08:00, 2 hours 30 minutes ago Une étude médico‑économique menée pour la première fois dans les pays du G7 démontre que le recours précoce à des tests de diagnostic rapides face au sepsis pourrait sauver des milliers de vies et générer des économies pour les systèmes de s
Published on 04/20/2026 at 07:00, 3 hours 30 minutes ago Invitation to the Annual and Extraordinary General Meeting of Shareholders
Published on 04/20/2026 at 07:00, 3 hours 30 minutes ago Uitnodiging voor de Jaarvergadering en Buitengewone Algemene Vergadering van aandeelhouders
Published on 04/20/2026 at 07:00, 3 hours 30 minutes ago Invitation to the Annual and Extraordinary General Meeting of Shareholders
